Reid G. Adler - May 2, 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF LEGAL OFFICER
Signature
/s/ Jerrold D. Doston, Attorney-in-Fact
Stock symbol
VTGN
Transactions as of
May 2, 2022
Transactions value $
$0
Form type
4
Date filed
5/3/2022, 05:10 PM
Next filing
Aug 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VTGN Stock Options (right to buy) Award $0 +200K $0.00 200K May 2, 2022 Common Stock 200K $1.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the stock options vest on May 2, 2023 (the "Vesting Start Date") and 1/36th of the remaining number of shares vest monthly thereafter until all awarded shares are fully vested three (3) years after the Vesting Start Date.